PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

50.09 0.17 −0.34%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

PACS Group, Inc. (PACS) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, PACS Group, Inc. (PACS) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.2× (September 2025) to 1.9× (September 2024); the current reading is higher than 87% of that period. That is in line with the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.2× 134.07%
FY2024 0.5× (54.97%)
FY2023 1.1× 0.00%
FY2022 1.1× 0.00%
FY2021 1.1× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.2× (3.93%)
Jun 2026 1.2× 31.17%
Mar 2026 0.9× (19.38%)
Dec 2025 1.2× 191.77%
11 more quarters

Against its own ten years

Low 0.2× High 1.9×
Ten-year median 1.0×
Current reading's percentile 87

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PACS